Trevor Hallam

Company: Sutro Biopharma

Job title: Chief Scientific Officer & President, Research

Seminars:

Providing an Overview of How Sutro Biopharma Are Targeting Folate Receptor α 4:00 pm

Discussing STRO-002 Phase 1 Clinical Study for patients with Advanced Ovarian Cancer as well as other indications Outlining how Sutro Biopharma are targeting FOLR-alphaRead more

day: day 2- pm

Industry Leaders’ Panel Discussion 8:30 am

Outlining the most exciting developments within the last 12 months Exploring what the current clinical and commercialization landscape looks like Sharing the biggest up and coming trends within the ADC field Examining the next big challenges ADC developers will faceRead more

day: day 1- am